A subgroup of COPD patients with a contribution of immune mechanisms to lung function impairment has been described; these patients are characterized by elevated eosinophil leukocyte counts and/or high IgE levels; combined treatment with an inhaled corticosteroid and long-acting bronchodilator has been advocated for this subgroup [31]. The gene discussed is IGHE; the disease is chronic obstructive pulmonary disease.